The prostate cancer center of Ewha Womans University Urology Institute is the most common male cancer in developed Western countries, and Korea is also providing various and effective treatments for prostate cancer, which is rapidly increasing in recent years.
For local prostate cancer, surgery is performed to preserve nerve blood vessels to maintain sexual life after surgery, and various surgical treatments and radiation treatments are performed, focusing on robotic surgery using Da Vinci Xi surgical robots.
Local progressive prostate cancer is actively treated with surgery or combination of radiation therapy and hormone therapy, hormone therapy for metastatic prostate cancer, chemotherapy for hormonal refractory prostate cancer, and new clinical trial treatments are performed to treat prostate cancer professionally and effectively tailored to patients.
Day-to-Day Diagnosis System for Prostate Cancer at Ewha Womans University Urology Institute
The Day-to-Day diagnosis system for prostate cancer at Ewha Womans University Urology Institute is a one-stop service that provides MRI scans and prostate biopsy on the day of treatment if prostate cancer is suspected (prostate-specific antigen, PSA rise). However, phone interviews with medical staff at Ewha Womans University Urology Hospital should take precedence because it is necessary to check the drug you are taking and fast before the test.
Inquiries about the Day-toDay diagnosis system for prostate cancer.
Call Center 1666-5000
Easy Appointment ▶ Are you a prostate cancer Day-to-Day diagnosis system? Check
The prostate cancer center at Ewha Womans University Urology Institute is the most common male cancer in developed countries in Europe and America, and Korea is also providing various and effective treatments for prostate cancer, which has recently increased rapidly. For local prostate cancer, nerve vessels are preserved to maintain sexual life after surgery, and various surgical treatments and radiation treatments are performed mainly on robotic surgery using Da Vinci Xi surgical robots. Local progressive prostate cancer is actively treated with surgery or combined radiation therapy and hormone therapy, and prostate cancer is treated professionally and effectively for patients by performing hormone therapy for metastatic prostate cancer, chemotherapy for hormone-unresponsive prostate cancer, and clinical trial new drug treatment.
The prostate cancer center at Ewha Womans University Urology Institute has wings by recruiting Professor Kim Cheong-soo of Asan Medical Center, who has the most experience in treating prostate cancer in Korea, as the head of the center.
Professor Kim Cheong-soo has performed a total of 3,800 prostate cancer surgeries so far, and specifically, has the best performance in Korea with 1,100 open surgery and 2,700 robotic surgery. In addition, he has published more than 370 papers on urinary cancer, served as the head of Asan Institute of Life Sciences at Asan Medical Center, chairman of the Korean Society of Prostate Radiology, and has been introduced several times in EBS and major central daily newspapers.
Professor Kim Chung-soo, Professor Kim Wan-seok, Shin Tae-young, and Professor Ryu Ho-young, who have extensive experience in robotic surgery, and experienced and talented experts such as Professor Cho Jung-min of hematologic oncology, Professor Jeong Won-geun of radiology, and Professor Park Sang-hee of pathology, gather together to provide the best cooperative treatment for each patient.
The prostate cancer center of Ewha Womans University Urology Institute, which already operates the latest robot system Da Vinci Xi, introduces the 4th generation of the latest robotic surgery machine, Da Vinci SP system, and introduces BK's latest ultrasound device to provide patients with the best medical service.